Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Gastroenterology. 2019 Sep 26;158(2):368–388. doi: 10.1053/j.gastro.2019.06.047

Figure 1.

Figure 1.

Complexities of CRC chemoprevention. There are many factors to consider in evaluating CRC chemoprevention agents, including the intrinsic properties of the agent (side effects, cost, ease of administration), mechanisms of chemoprevention, and groups most likely to benefit with the least risk.